Financhill
Sell
49

UNF Quote, Financials, Valuation and Earnings

Last price:
$184.76
Seasonality move :
5.63%
Day range:
$186.37 - $190.06
52-week range:
$149.58 - $243.70
Dividend yield:
0.72%
P/E ratio:
23.36x
P/S ratio:
1.43x
P/B ratio:
1.63x
Volume:
54.9K
Avg. volume:
108.7K
1-year change:
14.44%
Market cap:
$3.5B
Revenue:
$2.4B
EPS (TTM):
$8.04

Earnings Data

Next earnings date for UNF
Jun 26
2025
Most recent earnings per share
$1.31
Missed by $0.03
(Apr 2/2025)
Consensus Estimate
$1.34
(Apr 2/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

UNF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/26/2025 Q2 $614.5M -- -- $2.09 --
04/02/2025 Q1 $602.8M $602.2M $1.31 $1.34 -$0.03
01/08/2025 Q4 $606.6M $604.9M $2.31 $2.21 $0.10
10/23/2024 Q3 $634.7M $639.9M $2.39 $2.05 $0.34
06/26/2024 Q2 $601.3M $603.3M $2.03 $1.86 $0.17
03/27/2024 Q1 $587.8M $590.7M $1.09 $1.43 -$0.34
01/03/2024 Q4 -- -- $2.26 $2.18 $0.08
10/18/2023 Q3 -- -- $1.47 $1.63 -$0.16
06/28/2023 Q2 -- -- $1.29 $1.75 -$0.46
03/29/2023 Q1 -- -- $0.95 $1.44 -$0.49
01/04/2023 Q4 -- -- $1.81 $1.95 -$0.14
10/19/2022 Q3 -- -- $1.39 $1.73 -$0.34
06/29/2022 Q2 -- -- $1.33 $1.90 -$0.57
03/30/2022 Q1 -- -- $0.97 $1.63 -$0.66
01/05/2022 Q4 -- -- $1.77 $1.95 -$0.18
10/20/2021 Q3 -- -- $1.82 $1.83 -$0.01
06/30/2021 Q2 -- -- $2.21 $1.84 $0.38
03/31/2021 Q1 -- -- $1.71 $1.68 $0.03
01/06/2021 Q4 -- -- $2.20 $1.68 $0.53
10/21/2020 Q3 -- -- $1.66 $1.65 $0.01
07/01/2020 Q2 -- -- $1.12 $1.42 -$0.30
04/01/2020 Q1 -- -- $1.82 $1.67 $0.15
01/08/2020 Q4 -- -- $2.52 $2.02 $0.50
10/23/2019 Q3 -- -- $2.40 $1.94 $0.46
06/26/2019 Q2 -- -- $2.46 $1.70 $0.76
03/27/2019 Q1 -- -- $2.48 $1.52 $0.96
01/03/2019 Q4 -- -- $1.99 $1.90 $0.09
10/17/2018 Q3 -- -- $1.81 $1.65 $0.17
06/27/2018 Q2 -- -- $1.85 -- --
03/28/2018 Q1 -- -- $2.85 -- --
01/04/2018 Q4 -- -- $1.67 -- --
10/18/2017 Q3 -- -- -$0.25 -- --
06/28/2017 Q2 -- -- $1.19 -- --
03/29/2017 Q1 -- -- $1.10 -- --
01/04/2017 Q4 -- -- $1.38 -- --
10/19/2016 Q3 -- -- $1.74 -- --
06/29/2016 Q2 -- -- $1.49 -- --
03/30/2016 Q1 -- -- $1.16 -- --
01/06/2016 Q4 -- -- $1.78 -- --
10/21/2015 Q3 -- -- $1.43 -- --
07/01/2015 Q2 -- -- $1.61 -- --

UniFirst Earnings Questions

  • How Much did UniFirst Generate in Revenue Last Quarter?

    UniFirst reported $602.2M worth of top line sales in its most recent quarter.

  • Did UniFirst Beat Earnings Last Quarter?

    UniFirst announced earnings per share of $1.31 which represents a miss of analyst forecast a $1.34 per share.

  • Is UniFirst Profitable?

    UniFirst reported $208.1M that represents $11.16 per share over the last quarter.

  • What is the Analyst Consensus for UniFirst EPS Next Year?

    UniFirst's earnings are forecast to grow from $7.77 per share to $7.84 per share next year representing an increase of 1.82%.

  • When is UniFirst's Earnings Date?

    UniFirst's next earnings date is June 26, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.

Buy
64
AKRO alert for May 21

Akero Therapeutics [AKRO] is up 1.56% over the past day.

Buy
76
AGYS alert for May 21

Agilysys [AGYS] is down 1.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock